Madridge Journal of Cancer Study & Research

ISSN: 2640-5180

5th International Conference on Oncology & Virology
July 25-26, 2019 | Holiday Inn Rome Aurelia, Rome, Italy

Drosophila as a Model Organism in Cancer Research

Daniela Grifoni

Department of Pharmacy and Biotechnology, University of Bologna, Italy

DOI: 10.18689/2640-5180.a4.009

Download PDF

Essential mechanisms at the basis of cancer are conserved across metazoans. In the last decades, the cancer community has developed several cellular and animal models that have greatly helped elucidate fundamental processes at work during cancer initiation and progression. In particular, the fruit fly Drosophila has been contributing relevant literature to the field. The conservation in the fruit fly of the genes and signalling pathways implicated in mammalian tumorigenesis and the availability of sophisticated systems favouring tailored genetic manipulation have made Drosophila a prominent model in cancer research. Despite obvious differences in organ anatomy, Drosophila studies have unveiled an amazing functional conservation of the physiology at the basis of organ development and maintenance. In parallel, dysfunction of key genes found deregulated in human cancers has been shown to promote tumour formation in the fly, fostering the development of humanised models bearing specific genetic alterations. I will present an overview of the manifold applications of Drosophila in cancer research, dwelling on some key findings from our lab illustrating how a biological phenomenon associated with cancer growth in the fruit fly can be profitably investigated in human cancers.

Daniela Grifoni is a geneticist and cell biologist who uses the fruit fly, Drosophila, to understand cancer, mainly focusing on the impact of MYC and cell competition on cancer initiation and progression. She obtained a PhD in Genetic Sciences at Ferrara University and a Specialty in Applied Genetics at University of Bologna. Daniela Grifoni is Adjunct Professor and Research Associate at the Department of Pharmacy and Biotechnology, University of Bologna, where she leads the CanceЯEvolutionLab (